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ABSTRACT  
Objectives: The current study aims to evaluate dosage form preferences in children and 
young adults together with identifying the key pragmatic dosage-form characteristics that 
would enable appropriate formulation of orally disintegrating tablets (ODTs).  
Methods: International, multisite, cross-sectional questionnaire of children and young adults 
aged from 6-18 years. Eligibility was based on age, ability to communicate and previous 
experience in taking medications. The study was carried out at three locations; United 
Kingdom, Saudi Arabia and Jordan. The questionnaire instrument was designed for participant 
self-completion under supervision of the study team.  
Results: 104 questionnaires were completed by the study cohort (n=120, response rate 87%). 
Results showed that ODTs were the most preferred oral dosage forms (58%) followed by 
liquids (20%), tablets (12%) and capsules (11%). The preferred colours were pink or white 
while the preferred size was small (< 8mm) with a round shape. With regards to flavour, 
strawberry was the most preferred (30.8%) while orange was the least preferred (5.8%). The 
results also showed that the most important physical charcterstics of ODTs were disintegration 
time followed by taste, size, and flavour respectively. 
Conclusions: The results of our study support the World Health Organisation’s (WHO) claim 
for a shift of paradigm from liquid towards ODTs dosage forms for drug administration to young 
children older than 6 years. Data from this study will also equip formulators to prioritise 
development of key physical/performance attributes within the delivery system.  
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INTRODUCTION 
Paediatric drug administration has gained significant attention over the last 5–7 years. 
Pharmacists and other healthcare professionals in the pharmaceutical industry face a myriad 
of challenges facing drug development is the appropriate choice of the dosage forms for drug 
administration to this important target population.1 For this reason, the common trend has 
been the manipulation of adult dosage forms into a form that can be administered to of 
difficulties with regard to administration of drugs to children and young people. However, 
existing knowledge in this field is limited, making it difficult to identify viable solutions. The 
European Regulation on medicinal products2 stipulates that all formulations produced for 
young people should include safety measures such as assessment of excipient toxicity, 
appropriate delivery system capable of offering dose flexibility and should generally be 
acceptable to the target population.  
The term paediatric dosage forms need to suffice for a wide age range including neonates to 
adolescents (0 to 16 yrs). The common oral paediatric dosage forms in use are: solid dosage 
forms (such as tablets), powders, solutions, and syrups.3 For oral paediatric medicines to be 
acceptable to young patients there are a number of factors that need to be considered, 
especially elegance and palatability. Elegance refers to the outward appearance of the dosage 
form and its appeal to the end user. This may be particularly important for children and their 
adherence to medication regimens.2 Palatability is closely related to elegance and is a factor 
related to acceptability. Children will rarely take drugs that are bitter tasting.4 Therefore, any 
active ingredients with a bitter taste are often coated with a sweet tasting substance. If the 
unacceptable taste is not masked, such drugs may predispose the child to reject the medicine. 
If the smell of the drug is unpleasant, it may also negatively influence the acceptability of the 
drug. The term convenience refers to the method by which it is administered, for instance, as 
a tablet, syrup or as a powder. Oral liquid drug preparations, including solutions, syrups, 
emulsion and suspension, are considered as the most suitable oral formulation for children, 
since they are developed for younger new-borns unable to swallow tablets and accommodate 
palatability and dose adjustment changes required by children.5- 6 
Nonetheless, liquid formulations present several drawbacks, such as low stability, difficulties 
in taste masking, inappropriate excipients for children (e.g. propylene glycol, benzyl alcohol,) 
and low transportability.2, 7 The World Health Organisation (WHO) recognizes the need to 
develop drugs and formulations that specifically target children. According to WHO, the 
dosage form should be both acceptable and palatable.8 Furthermore, whenever possible the 
drug formulation should be palatable without the need to further mask the taste. Dosage 
form acceptability, which encapsulates a multitude of factors including preference, 
palatability, presentation and ease of use, has a significant influence on paediatric patient 
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compliance2.  ODTs may increase bioavailability and faster onset of action in adults and 
children, since dispersion in saliva in oral cavity causes pre-gastric absorption from some 
water soluble actives.  Taste and flavour together primarily determine the acceptability of 
ODTs .9 Any pre-gastric absorption avoids first pass metabolism and can be of a great 
advantage in drugs that undergo extensive hepatic metabolism. The study described in this 
paper was designed with two key objectives: (1) to evaluate dosage form preferences for a 
wide range of formulations (liquids, injections, suppositories, solid dosage forms, patches) 
among children and young adults who have a history of taking medicines.  The study was 
conducted in three regions (UK, Saudi Arabia and Jordan) at five different centres. These 
were Birmingham Children’s Hospital (UK), Nottingham Children’s Hospital (UK), Najran 
maternity and children hospital (Saudi Arabia), General Thar Hospital (Saudi Arabia) and 
Speciality Hospital (Jordan). Countries were chosen based on diverse geographical regions 
and ethnic mix, ease of access to suitable subjects, lack of published data regarding children 
preferences of dosage forms. In addition, (2) the study would provide pragmatic and 
translatable outcomes to support formulating stable and acceptable dosage forms. It is 
recognised that commonly prescribed liquid formulations used in hot and humid middle 
eastern countries can present significant stability issues.10 
 
METHODS 
Study Design 
Multi-national, five-site, participant-supported questionnaire of children aged 6–18 years 
following a demonstration of orally disintegrating tablets. The questionnaire was conducted in 
both English and Arabic languages. 
 
The Questionnaire 
A suitable method to collect and understand a stance to a hypothesis is a Questionnaire.11 
The questionnaire was developed by an iterative process between the study team and 
paediatric based healthcare professionals. The final questionnaire consisted of four sections. 
These were:  demographic and educational data including gender, age, and education; 
participant experience of taking medicines and their preferences for various oral dosage forms 
(liquids, tablets, capsules and ODTs); preference for colour, shape, size, thickness, taste, 
flavour and disintegration time of tablets;   participant feedback about the questionnaire. 
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Ethical approval 
The study was conducted at five centres; in England (2 hospitals), Saudi Arabia (2 hospitals) 
and Jordan (1 hospital). Birmingham Children’s Hospital Research and Development provided 
the necessary research governance approval. The Pharmacy Academic Practice Unit at the 
Birmingham Children’s Hospital oversaw the study. Consultation centres in Saudi Arabia and 
Jordan received a copy of the approved letter for the study. 
Exclusion criteria and some challenges 
Exclusion criteria included: 
 
 Under 6 years of age 
 Over 18 years of age 
 Perceived difficulty in age appropriate communication (e.g. the capacity to understand 
and responding to the questionnaire questions). 
 No history of taking any medication 
 
Statistical analysis  
Participant responses were entered into MS Excel 2007 for analysis. The 2 test was used to 
examine the independence in the data that was collected. The level of significance was chosen 
to be 0.05. Two-way analysis of variance (ANOVA) was used to compare data per age groups 
and per gender. Statistical analysis was performed using Graph Pad Prism software. 
 
RESULTS  
A total of 104 questionnaires (study cohort n=120, response rate 87%) were completed. The 
objective of the study was to determine the preference for pharmaceutical dosage forms in the 
study population. A presentation concerning the different dosage forms was delivered to the 
participants in an open-forum style, prior to completion of the questionnaire. This allowed for 
both proactive and interactive contribution from the participants. The participants were allowed 
to ask questions concerning dosage formulations 
Questionnaire results 
Section one: Demographic and educational background of participants 
Table 1 summarises the demographic characteristics of participants. It gives the breakdown 
of their gender, age and educational level. Jordan had the highest percentage of participants 
6 
 
who had basic education as their highest educational level (100%). This was followed by Saudi 
Arabia (97%) and the United Kingdom (69%). This is a significant difference between the 
participant countries (p=0.0001). 
Table 1. Demographic characteristics of participants 
Characteristics UK 
N=29 
(%) 
Saudi Arabia 
N=41 
(%) 
Jordan 
N=34 
(%) 
Total 
N=104 
(%) 
P value 
 
Gender 
Male 8 (27.6%) 26(63.4%) 18(52.9%) 52(50%) >0.05** 
Female 21(72.4%) 15(36.6%) 16(47.0%) 52(50%) 
Age 
in years 
6-8 0 (0%) 7(17.0%) 10(29.4%) 17(16.3%) p>0.05 for age 
group 
p=0.001 for 
regions)* 
9-11 4 (13.8%) 14(34.2%) 14(41.2%) 32(30.8%) 
12-14 8 (27.6%) 12(29.3%) 10(29.4%) 30(28.8%) 
15-18 17(58.6%) 8(19.5%) 0 (0%) 25(24%) 
Educational 
level 
School 20(69%) 40(97.6%) 34(100%) 94(90.4%) 0.0001** 
Higher 
education 
9 (31%) 0 (0%) 0 (0%) 9 (8.7%) 
Working 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Other 0 (0%) 1(2.4%) 0 (0%) 1(0.9%) 
*Two way- ANOVA  **Chi-Square 
 
Section two: experience of taking medicines and preferred dosage forms 
Females had the highest frequency of taking daily medicines (28.6%). On a weekly and 
monthly basis, the male participants recorded a higher frequency of taking medicine than 
females (27% and 31% respectively). Figure-1 demonstrates that oral route (tablets) was more 
popular across both the genders compared to liquids, capsules, powders and other dosage 
forms. 
 
 
7 
 
Figure 1 Distribution of the patients’ preferences of dosage forms according to gender for all 
regions. 
Furthermore, male participants (54%) registered their preference for tablets as compared to 
the female participants. In order to explore further their preference for oral route, the 
participants were asked for their preferred oral dosage forms. The results showed (Figure 2) 
that orally disintegrating tablets scored higher than tablets, capsules and liquids across the 
various different centres.   
 
Figure 2 Distribution of paediatrics who preferred oral dosage form according to regions. 
Section three:  Physical characteristics results for orally disintegrating tablets (ODTs) 
As the first part of the study concluded that the orally disintegrating tablets were the preferred 
dosage forms, the next set of investigations were centred around evaluating the preference of 
different attributes of ODT such as colour, taste, shape, flavour  and disintegration time. Pink 
was the preferred colour for ODTs by more than a quarter of the respondents (30.8%) followed 
by white (26.0%), blue (14.4%), yellow (11.5%), orange (7.7%) and finally purple (7.7%). The 
majority of the participants preferred ODTs that are round in shape. This accounted for 35.6% 
of the responses while the heart shape was second with a preference of 22.1%. Least 
preferred shapes were square (4.7%) and diamond (1.9%). With regard to flavour, strawberry 
was the most preferred (30.8%) while orange was the least preferred (5.8%). 
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Figure 3 Distribution of the preferred colour by age group and gender. 
Preferred Oral Dosage Forms 
In our study, results show that ODTs were the most popular oral dosage forms (58%) followed 
by liquids (20%), tablets (12%) and capsules (11%).  
Regional analysis of the data from preferred oral dosage forms indicated that ODTs was the 
most preferred by the majority of respondents (66%, 65%, and 38%) for Saudi Arabia, Jordan 
and UK respectively (Figure-2). Analysis of distribution of responses for ODTs as preferred 
oral dosage form according to age group and gender in all regions showed a highest 
percentage of the children were male between 12-14 years of age who preferred ODTs 
(44.83%) followed by females between age group of 11-13 years (38.7%). However, there 
was no significant difference according to age group and gender (p=0.503). 
 
Our study exposed an interesting result in which genders and age group have different colour 
preferences for ODTs.  For example, 28 out of 33 female participants preferred pink colour 
ODTs while 17 out of 28 male participants prefer white.12 An extremely significant difference 
was detected by Chi- square test in colour preferences (p=0.0001). Similarly, results showed 
that there was a significant level of distribution of the preferred colour by age group and gender 
(p=0.0351). The majority of female (6-8 years) respondents (85.7%) preferred pink colour 
ODTs while the highest percentage preference for white was recorded for male participants 
(12-14 years) (38.9%) see (Figure 3). 
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With respect to the regional preferences, English and Jordanian participants did not prefer 
square shaped tablets while around 12% from Saudi preferred square shape.  
The size and thickness of a dosage form is vital in its acceptability.14 Small sized (0.15 cm3 
±0.002) ODTs were most preferred (64.42%) compared to the medium 33.65% (0.27 
cm3±0.006) or large 1.92% (0.33 cm3±0.006) ODTs.  
Our results demonstrate that the preference for small sized ODTs cuts across all age groups 
(p>0.05) and gender for all study regions. 
Analysis of thickness of ODTs also, highlights the preference of the participants for thin 
formulations at the expense of thick ODTs. The majority of respondents (66.35%) preferred 
thinner ODTs (1.14mm ± 0.002); however, 33.65% of the participants preferred thicker ODTs 
(2.47mm ± 0.03). 
 
 
 
Taste and flavour Preferences 
The taste of a drug is the result of a perception initiated by afferent sensors in the tongue; and 
may be sweet, neutral, bitter or salty. Flavour is usually a result of the addition of excipients. 
In this present study the majority of the participants (76.9%) preferred sweet taste.  
 
With regard to flavour, strawberry was the most preferred (30.8%) while orange was the least 
preferred (5.8%).  
When considering flavour preference by gender, it was found that strawberry was the most 
preferred flavour by female participants (47.1%). On the other hand, 22.6% of male 
participants preferred lemon followed by mint (17%), then chocolate and strawberry with 
15.1% each (Figure-4).  
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Figure 4 Distribution of preferred orally disintegrating tablet (ODT) flavours for all regions by gender. 
Although, overall strawberry was the most preferred flavour, significant differences were found 
among participant preferences according to the geographical regions. Lemon was the second 
most preferred flavour in Saudi children (24%) while it was the least with British (3%) 
participants.   
The majority of the participants (87.5%) preferred very rapidly (<30sec) disintegrating ODTs 
followed by rapidly (10.6%), and the least preference was for ODTs that would disintegrate 
between 1.5 and 3 minutes (1.9%) respectively.  
 
The results obtained for the analysis of the physical characteristics of ODTs showed that 
25.0% rated the duration for tablet disintegration in the mouth as the most important 
characteristic, followed by the taste (24.1%), size (15.7%), and flavour (13.8%) respectively 
as shown in Figure-5. Nearly, similar results were found by Ibrahim et al.  with respect to the 
importance of the physical characteristics of oral solid dosage forms, with slightly more than 
half (52%) of the respondents ranking the size as the most important followed by taste (40%), 
shape (13.6%), and colour (13.4%) respectively.  
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Figure 5 Distribution of the most preferred characters of orally disintegrating tablets (ODTs) for 
all regions. 
 
Discussion  
The current study explores the preference of children not only for the route of administration 
of medicines but also investigates the preferred oral dosage form. This study for the first time 
also incorporates elements of pharmaceutical development attributes that should be taken on 
board when developing medicines for children.  
Alhaddad et al. cross- sectional study for people above 18 years found that tablets (69.6%) 
and capsules (37.6%) represented the highest preferred dosage forms. It was recommended 
that prescribers should prescribe to patients their preferred dosage forms, to improve 
medication adherence, and hence improve outcomes.14 Interestingly, in our study there was 
no significant difference among gender p>0.05 (Chi square test) in their preferences. 
However, there is a significant difference according to dosage where suppositories and 
injections were the least preferred dosage forms p<0.05. 
The popularity of ODTs in the pediatric population is possibly due to a number of factors 
including ease of administration, stability and convenience of storage (as opposed to liquids). 
However, a study by  Ibrahim15 showed that capsules were the most prefered oral solid dosage 
forms when compared to tablets, caplets and soft gel.  Ibrahim  results also showed that 
ethinicity and age group directly influenced the participants preferences of oral dosage forms.  
For example, capsules were prefered by both Malays and Chinese.15 
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The superiority of ODTs as a preferred alternative to capsules and conventional tablets is 
possibly due to better patient compliance as it does not require water for administration and 
the tablet disintegrates and dissolves in the oral cavity within seconds.16 Capsules were the 
second preferred form by UK respondents; possible explanation for this preference includes 
the ability to distinguish it from dosage forms as well as easier to swallow.17 Another possible 
explanation for the preference of capsules could be attributed to the previous experience of 
the participants in taking capsules over liquid or tablet dosage forms. 
As for the preferences of the white colour, followed by blue oral dosage forms, investigations 
by Ibrahim et al.15 Among 350 participants in Malaysia, the study found that white was the 
preferred colour by more than half of the respondents (55%) followed by blue (20%). While 
round shape was the preferred in our results, similarly, in another study in the adult population, 
53% preferred round shape tablets.15 Surprisingly, in-vitro studies recommended that flat 
tablets have greater adherence to the oesophagus than caplets.18 Furthermore, oval tablets 
may be easier to swallow and have faster oesophageal transit times than round tablets.19   
In this study, participants felt that small ODTs are easier or more comfortable to swallow than 
larger ones. In 2001, Overgaard et al.20 results showed that difficulty in swallowing increased 
with an increase in tablet size. The size of dosage forms may affect the transit through the 
pharynx and oesophagus and may directly affect a patient’s ability to swallow. Larger tablets 
and capsules have been reported to extend oesophageal transit time. This can give rise to 
disintegration of the product in the oesophagus, resulting in pain and localized oesophagitis.21  
Sweet taste preference in our study for paediatric population is contrasted in another published 
study evaluated the most preferred oral solid dosage forms (OSDF) in adult participants. More 
than half (55.0%) of participants preferred their OSDF to be without taste while 40.7% 
preferred sweet taste.15 According to other studies, the preference for sweet taste remains 
high throughout childhood22 and then switches to neutral during late adolescence.23 
Furthermore, Pepino et al. reported that not only do children prefer sweet taste, but sweet 
tasting solutions in the oral cavity supposedly decreases pain in both infants and children, 
probably via the involvement of the endogenous opioid system. Therefore, it is not surprising 
that many oral formulations for children are sweetened.24  
Strawberry preference in our study group was confirmed by other studies. For example, a 
study was carried out in 48 healthy schoolchildren in Tanzania and results showed that cherry 
flavour appeared favourable to ensure a high acceptability of anti-malarial dispersible tablets 
in small infants and children.25  
A possible explanation could be that strawberry is found as a common flavouring in various 
food additives and is effective even at low concentration.26 
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According to the European Medicines Agency (EMA),2 cherry and strawberry flavours were 
most preferred in medication for pain and infectious diseases within the European paediatric 
population; whereas lemon, peppermint and orange were recommended for indigestion 
remedies. 
 
Upon in-depth analysis of the most preferred ODT’s properties particularly speed of 
disintegration, taste and flavour, most participants believed that some tablets have a bad taste 
and that rapid disintegration would ensure unpleasant taste can be reduced by quickly 
swallowing the contents of the tablet. Additionally, pleasant flavour and taste will support their 
whole experience particularly those on chronic medications – and may ultimately support 
adherence. This study has identified the favoured medication characteristics as expressed by 
the participants. However it has not been tested whether these desirable characteristics are 
deliverable due to the physical properties of the active ingredients. Similarly the potential 
benefits in terms of patient adherence are implied only, and have not been tested in this 
present study. 
CONCLUSION  
The general outcome was that solid dosage forms are the preferred dosage forms and orally 
disintegrating tablets are a preferred dosage form for children and young adults. The benefits 
that accrue to ODTs include safety, higher compliance, dose accuracy, stability and ease of 
swallowing. Within the paediatric population, orally disintegrating tablets are more convenient 
because they combine the advantages of both solid and liquid dosage forms but without 
incorporating their disadvantages such as difficulty in swallowing and lack of stability. From 
the results in the current study, it can be concluded that the most preferred colours were pink 
and white, the most preferred size is the small sized tablets and the most preferred shape was 
round with strawberry flavoured. Similarly, physical characteristics in order of priority with 
regard to the acceptability of ODTs included disintegration time, taste, size and flavour. 
  
Key messages  
What is already known in this subject 
 The main challenge facing drug development in paediatric dosage forms is the 
appropriate choice of the dosage forms for drug administration to this important 
target population 
 There are many dosage forms available for children, and it’s safety and dosage 
flexibility is important 
 Acceptance of medicines by children needs to be considered by drug formulation 
designers, as factors such as palatability and elegance may affect this 
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 Orally disintegrating tablets is a dosage formulation design available and possible for 
paediatric medicines 
What this study adds 
 Based on a questionnaire from paediatric patients across five centres in three 
countries internationally, orally disintegrating tablets are the preferred dosage form 
for children and young adults in comparison to tablets, capsules and liquids 
 Formulation of ODTs and their physical characteristics are of high importance in 
supporting patient adherence for children to use a particular medicine. 
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